The existence of intestinal microbiota in the plasma as well as increased plasma levels of gut permeability markers fatty acid binding protein 2 (FABP2), lipopolysaccharides (LPS) and peptidoglycan (PGN) indicated the intestinal barrier dysfunction in COVID-19 (93). This evidence concerns the gene FABP2 and COVID-19.